ONCO Onconetix, Inc. Expected net earnings per share growth this year

Official company branding of Onconetix, Inc. (ONCO)

How does Onconetix, Inc. (ONCO) plan to monetize prostate cancer diagnostics? Year-over-year EPS growth demonstrates the current trend, where 0.00 captures the magnitude of this parameter. Stable demand for urology offsets macroeconomic shocks, while the updated management is currently focusing on the commercialization of new developments and the stabilization of device sales.

Earnings per share growth in current year: Onconetix Corporation (ONCO) for 02/21/2024 - 11/17/2026

Analytical breakdowns and data insights for company Onconetix Corporation (ONCO)

- current quotes and average value forecast:
Basic company analysis:Onconetix Corp
Core merchandise of Onconetix Corp

Investors must assess the volatility risk of Onconetix, Inc. (ONCO) by analyzing the dynamics of net earnings per share. The operational resilience of the business is currently driven by the commercial success of Entadfi and the implementation of urological diagnostics. The current value of 0.00 in the annual earnings per share history reflects the market consensus regarding revenue growth rates, confirming the fundamental reliability of the product line expansion strategy.

Direct competitors

Net earnings per share change in current year Agilent Tech A|Earnings per share growth in current year Quest Corp|Illumina, Inc. (ILMN) - Expected net earnings per share growth this year|Earnings growth in current year EXAS|RVTY (Revvity) - Earnings per share increase in current year|Earnings per share growth in current year bio-rad.com BIO|NNNN: Earnings per share growth this year|Sotera Health Corp - Earnings growth in current year|Expected net earnings per share growth this year QuidelOrtho QDEL|OPK (OPKO Health) - Net earnings per share growth this year|Earnings per share growth rate in current year CareDx, Inc. (CDNA)|Net earnings per share growth this year MRVI|Earnings per share growth rate in current year Fulgent FLGT|Earnings per share growth in current year Standard BioTools Inc. (LAB)|CTKB (Cytek Biosciences, Inc.) - Earnings per share increase in current year|Earnings growth in current year OSUR (OraSure Corp)|Expected net earnings per share growth this year Exagen Inc. (XGN)|MDXH: Net earnings per share growth this year|Expected net earnings per share growth this year Lucid Diagnostics Inc LUCD|PRE (Prenetics Global Ltd) - Net earnings per share growth this year|Net earnings per share growth this year Insight Molecular|TRIB (Trinity Biotech) - Earnings growth in current year|Earnings per share growth in current year PRPH|Earnings growth in current year AIMD|Net earnings per one share growth for the current year CODX|Earnings per share growth in current year Heart Test Laboratories HSCS|BMRA: Earnings per share growth this year|CDIO - Earnings per share growth in current year|Expected net earnings per share growth this year Virax Biolabs Group Ltd VRAX|bluejaydx.com (BJDX) - Earnings per share growth in current year|Vermillion - Earnings per share increase in current year|AXDX (Accelerate Diagnostics Inc) - Earnings growth in current year|Net earnings per share growth this year CENTOGENE, N.V. (CNTG)|Net earnings per share growth this year ENZ (Enzo)|Earnings growth in current year Fresh2 Group Limited (FRES)|Earnings growth in current year GENE (GTG Labs)|ME - Net earnings per share growth this year|Psychemedics Inc - Earnings growth in current year